Saturday, 16th May
2015 Annual Meeting of the Australasian Society for Dermatology Research
Days
Friday, 15th May
Saturday, 16th May
Search
Speakers
Allergy and Autoimmunity
8:30AM - 10:30AM
Saturday, 16th May
Chair: Dedee Murrell
Regulatory B cells allergic and autoimmune diseases
-
Manabu Fujimoto
Post-hoc Analyses of the Effect of AN2728 Topical Ointment, 2% on Atopic Dermatitis-associated Pruritus
-
Lee Zane
Safety and Efficacy of AN2728 Topical Ointment, 2% in the Treatment of Children, Adolescents, and Adults with Atopic Dermatitis: Summary of the Phase 1b/2 Studies
-
Lee Zane
Atopic dermatitis severity scales: a comparison between four scales and evaluation of their use in patients with skin of colour
-
Cathy Y Zhao
Advances in outcome measures for blistering diseases – where are we now?
-
Dedee F Murrell
Characterising the severity and responsiveness of a new outcome measure for epidermolysis bullosa – The Epidermolysis Bullosa Disease Activity and Scarring Index
-
Swaranjali V Jain
The Rurality of Patients with Epidermolysis Bullosa in Australia: A Cross Sectional Study
-
Adam G Harris
A new variant of PAPA/PASH syndrome
-
Dunja A Vekic
Morning Tea
10:20AM - 10:50AM
Saturday, 16th May
Melanoma
11:50AM - 12:20PM
Saturday, 16th May
Chair: Amanda Oakley
Targeting melanoma with autologous peripheral blood GD2-specific chimeric antigen receptor T cells
-
Michael Brown
Cutaneous adverse reactions of anti-Programmed cell Death1 (anti-PD1) therapy in metastatic melanomas and other cancers
-
Shelley Ji Eun Hwang
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases: implications for adjuvant checkpoint inhibitors
-
Hojabr Kakavand
Comparison of Australian and German case-control studies melanoma: analysis of PGC-1a and PGC-1b coding variant alleles
-
Annette Pflugfelder
Mechanisms of BRAFi Induced hyperproliferative Cutaneous Conditions
-
Marina Ali
Lunch
12:20PM - 1:20PM
Saturday, 16th May
Skin Cancer
1:20PM - 3:10PM
Saturday, 16th May
Chair: Tarl Prow
A critical role for desmoglein-2 (DSG2) in melanoma vasculogenic mimicry
-
Lisa Ebert
Evaluating a brain tumour targeting fluorescent marker for melanoma and non-melanoma skin cancer activity in volunteers using in vivo fluorescence imaging
-
Miko Yamada
New approach of Gold nanoparticles for treating skin disease
-
Tarl Prow
Morphogenesis and carcinogenesis: two sides of the same coin?
-
Stephen Gilmore
No adverse biological impact was observed in hairless mice exposed to commercially available sunscreens containing nanoparticles of TiO2 and ZnO with or without UVR
-
Megan Osmond
Afternoon Tea
3:00PM - 3:30PM
Saturday, 16th May
Pigment Lesions
3:30PM - 4:30PM
Saturday, 16th May
Chair: Richard Sturm
Developing a vitiligo registry to promote translational research
-
Amit Pandya
Genetic association of dermoscopic nevus patterns in a Queensland case-control study of melanoma
-
Richard A Sturm
Reflectance confocal microscopy guided biobanking of melanocytic proliferations
-
Marco Ardigo
Clinical session II
4:30PM - 5:00PM
Saturday, 16th May
Chair: Rodney Sinclair
Hair Shedding In Women: How much is too much?
-
Rodney Sinclair
Female pattern hair loss: Combination therapy with low dose oral minoxidil and spironolactone
-
Rodney Sinclair
Inpatient dermatology referrals from an Australian tertiary hospital
-
Nigel G Maher
Closing Remarks & Awards by Nikolas Haass & Helmut Schaider
5:00PM - 5:10PM
Saturday, 16th May
Drinks and Canapés from 5.10 PM to 5.40 PM
← Friday